In the last trading session, 1.14 million shares of the Abeona Therapeutics Inc (NASDAQ:ABEO) were traded, and its beta was 1.69. Most recently the company’s share price was $4.92, and it changed around -$0.03 or -0.61% from the last close, which brings the market valuation of the company to $240.10M. ABEO currently trades at a discount to its 52-week high of $8.45, offering almost -71.75% off that amount. The share price’s 52-week low was $3.05, which indicates that the current value has risen by an impressive 38.01% since then. We note from Abeona Therapeutics Inc’s average daily trading volume that its 10-day average is 1.02 million shares, with the 3-month average coming to 457.39K.
Abeona Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended ABEO as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Abeona Therapeutics Inc is expected to report earnings per share of -0.36 for the current quarter.
Abeona Therapeutics Inc (NASDAQ:ABEO) trade information
Instantly ABEO has showed a red trend with a performance of -0.61% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 5.02 on recent trading dayincreased the stock’s daily price by 1.99%. The company’s shares are currently down -11.67% year-to-date, but still up 13.89% over the last five days. On the other hand, Abeona Therapeutics Inc (NASDAQ:ABEO) is -7.17% down in the 30-day period. We can see from the shorts that 2.21 million shares have been sold at a short interest cover period of 4.84 day(s).
The consensus price target as assigned by Wall Street analysts is $16, which translates to bulls needing to increase their stock price by 69.25% from its current value. Analyst projections state that ABEO is forecast to be at a low of $16 and a high of $16.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 47.21%. Abeona Therapeutics Inc earnings are expected to increase by 20.86% in 2025, but the outlook is positive 53.58% per year for the next five years.
ABEO Dividends
Abeona Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-Mar-19.
Abeona Therapeutics Inc (NASDAQ:ABEO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 6.59% of Abeona Therapeutics Inc shares, and 68.14% of them are in the hands of institutional investors. The stock currently has a share float of 72.95%.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.23 shares worth $6.06 million, making up 2.53% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 678.1 shares worth around $3.34 million, which represents about 1.39% of the total shares outstanding.
